Skip to main content
. Author manuscript; available in PMC: 2019 Feb 6.
Published in final edited form as: Neuropharmacology. 2018 Nov 2;145(Pt A):123–130. doi: 10.1016/j.neuropharm.2018.10.041

Fig. 3.

Fig. 3.

Proteomic analysis of Conditioned Medium. (A) Number of differentially secreted proteins identified by LC/MS in CM fraction A11 from vehicle treated CM. (B) Table of unique proteins identified in AICAR-CM fraction A11. Proteins highlighted in green indicate peptide coverage greater than 5%. (C) Kegg pathway analysis describing the most common pathways represented by proteins secreted from AICAR-treated CM and relative number of proteins in each pathway.